1 / 5

“TISSUE PLASMINOGEN ACTIVATOR” (t-PA) PLASMINOGEEN PLASMINE

“TISSUE PLASMINOGEN ACTIVATOR” (t-PA) PLASMINOGEEN PLASMINE (inactief) (actief) FIBRINE FRAGMENTEN (vast) (vloeibaar). IBL-1. IBL-2. t-PA MILESTONES 1979 : Ontdekking van “Bowes” melanoma cellijn als bron van t-PA

desiree-pratt
Télécharger la présentation

“TISSUE PLASMINOGEN ACTIVATOR” (t-PA) PLASMINOGEEN PLASMINE

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. “TISSUE PLASMINOGEN ACTIVATOR” (t-PA) PLASMINOGEEN PLASMINE (inactief) (actief) FIBRINE FRAGMENTEN (vast) (vloeibaar) IBL-1

  2. IBL-2

  3. t-PA MILESTONES 1979: Ontdekking van “Bowes” melanoma cellijn als bron van t-PA - Zuivering, biochemische en therapeutische karakterisering in Leuven - Samenwerking met Genentech gestart eind 1980 1982: Klonering van t-PA cDNA en productie van recombinant t-PA (rt-PA) - Karakterisering van rt-PA in Leuven en San Francisco - Klinische evaluatie gestart in 1984 1987: Registratie van rt-PA in USA - Van 1987 tot 2004 > 5 miljoen patienten met AMI behandeld > 120 miljoen € naar LRD, vzw (en opvolgers) IBL-3

  4. t-PA ROYALTIES 100 -17% overhead 83 -21.25% Belgische belastingen 66 33 33 LRD, vzw D. Collen 16.5 16.5 + 16.5 16.5 LRD, vzw D. Collen Research Foundation - mede-uitvinders - Thromb-X (NV) - Cotpa (charity) IBL-4

  5. Molecular Cardiovascular Medicine Group Katholieke Universiteit Leuven, Belgium Campus Gasthuisberg Director D. Collen, M.D., Ph.D. 9th floor KU LEUVEN Thromb-X, NV Center for Molecular and Vascular Biology Adjunct Directors H.R. Lijnen, Ph.D. Center for Transgene Technology and Gene Therapy Adjunct Director P. Carmeliet, M.D., Ph.D. Thromb-X, N.V. Managing Director J.M. Stassen, Ph.D. IBL-5

More Related